
Noble E. Jarrell
Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1622, 1625, 1699, 1609, 1629 |
| Total Applications | 1459 |
| Issued Applications | 965 |
| Pending Applications | 172 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18018872
[patent_doc_number] => 20220370371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/543450
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/543450 | GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY | Dec 5, 2021 | Abandoned |
Array
(
[id] => 20826288
[patent_doc_number] => 12679841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/541362
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3313
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541362
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541362 | Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors | Dec 2, 2021 | Issued |
Array
(
[id] => 20771463
[patent_doc_number] => 12655122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Heteroaryl carboxamide compound
[patent_app_type] => utility
[patent_app_number] => 18/254829
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18835
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254829
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254829 | Heteroaryl carboxamide compound | Nov 28, 2021 | Issued |
Array
(
[id] => 19571841
[patent_doc_number] => 20240376133
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-11-14
[patent_title] => CROSSLINKING COMONOMERS FOR HIGH PERFORMANCE DEGRADABLE THERMOSETS
[patent_app_type] => utility
[patent_app_number] => 18/035922
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035922
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035922 | CROSSLINKING COMONOMERS FOR HIGH PERFORMANCE DEGRADABLE THERMOSETS | Nov 8, 2021 | Pending |
Array
(
[id] => 19571841
[patent_doc_number] => 20240376133
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-11-14
[patent_title] => CROSSLINKING COMONOMERS FOR HIGH PERFORMANCE DEGRADABLE THERMOSETS
[patent_app_type] => utility
[patent_app_number] => 18/035922
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035922
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035922 | CROSSLINKING COMONOMERS FOR HIGH PERFORMANCE DEGRADABLE THERMOSETS | Nov 8, 2021 | Pending |
Array
(
[id] => 18939594
[patent_doc_number] => 20240034733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => KRAS G12D INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/034852
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034852
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/034852 | KRAS G12D INHIBITORS | Nov 1, 2021 | Pending |
Array
(
[id] => 18844646
[patent_doc_number] => 20230407050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHOD FOR STABILIZING AN ORGANIC MATERIAL USING A STABILIZER MIXTURE
[patent_app_type] => utility
[patent_app_number] => 18/035176
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035176 | METHOD FOR STABILIZING AN ORGANIC MATERIAL USING A STABILIZER MIXTURE | Oct 27, 2021 | Pending |
Array
(
[id] => 18817409
[patent_doc_number] => 20230391749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => CRYSTALLINE AND AMORPHOUS FORMS OF A DELTA-OPIOID MODULATOR
[patent_app_type] => utility
[patent_app_number] => 18/250915
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250915
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250915 | Crystalline and amorphous forms of a d-opioid modulator | Oct 26, 2021 | Issued |
Array
(
[id] => 18895137
[patent_doc_number] => 20240010622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => MITOCHONDRIAL ATP INHIBITORS TARGETING THE GAMMA SUBUNIT PREVENT METASTASIS
[patent_app_type] => utility
[patent_app_number] => 18/033266
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18033266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/033266 | MITOCHONDRIAL ATP INHIBITORS TARGETING THE GAMMA SUBUNIT PREVENT METASTASIS | Oct 21, 2021 | Pending |
Array
(
[id] => 17533607
[patent_doc_number] => 20220112216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/507922
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507922 | Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof | Oct 21, 2021 | Issued |
Array
(
[id] => 17791948
[patent_doc_number] => 20220251039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/451021
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/451021 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | Oct 14, 2021 | Pending |
Array
(
[id] => 18806797
[patent_doc_number] => 20230381129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => PERMETRIN FOR USE IN THE TREATMENT OF DEMODEX SPP INFESTATION
[patent_app_type] => utility
[patent_app_number] => 18/248949
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248949
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248949 | PERMETRIN FOR USE IN THE TREATMENT OF DEMODEX SPP INFESTATION | Oct 14, 2021 | Pending |
Array
(
[id] => 18212465
[patent_doc_number] => 20230058729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => MACROCYCLES AS FACTOR XIA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/493516
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493516 | Macrocycles as factor xia inhibitors | Oct 3, 2021 | Issued |
Array
(
[id] => 17343809
[patent_doc_number] => 20220010140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/482239
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482239
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482239 | Phthalocyanine dye compounds, conjugates and methods of use thereof | Sep 21, 2021 | Issued |
Array
(
[id] => 19763142
[patent_doc_number] => 12221415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Method for preparing 2,3-dichloro-5-trifluoromethylpyridine with high selectivity
[patent_app_type] => utility
[patent_app_number] => 17/478129
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9542
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478129 | Method for preparing 2,3-dichloro-5-trifluoromethylpyridine with high selectivity | Sep 16, 2021 | Issued |
Array
(
[id] => 18657633
[patent_doc_number] => 20230303562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018440
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018440
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018440 | Pyrazole compound and preparation method therefor and use thereof | Sep 16, 2021 | Issued |
Array
(
[id] => 19345126
[patent_doc_number] => 20240254089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/245700
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245700
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245700 | MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS | Sep 15, 2021 | Pending |
Array
(
[id] => 18725725
[patent_doc_number] => 20230339919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/044881
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044881
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044881 | BENZO OXYGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL APPLICATION THEREOF | Sep 9, 2021 | Pending |
Array
(
[id] => 19003568
[patent_doc_number] => 20240067639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS
[patent_app_type] => utility
[patent_app_number] => 18/044260
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044260
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044260 | SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS | Sep 7, 2021 | Pending |
Array
(
[id] => 18937402
[patent_doc_number] => 20240032541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => HERBICIDAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/044821
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044821
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044821 | HERBICIDAL COMPOUNDS | Sep 5, 2021 | Pending |